June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Retinoschisin-1 (RS1) is required for proper functioning of luminance and red–green cone-opponent mechanisms
Author Affiliations & Notes
  • Ditta Zobor
    Department of Ophthalmology, Semmelweis Egyetem, Budapest, Budapest, Hungary
  • Barbara Besztercei
    Department of Ophthalmology, Semmelweis Egyetem, Budapest, Budapest, Hungary
  • Balazs Lesch
    Department of Ophthalmology, Semmelweis Egyetem, Budapest, Budapest, Hungary
  • J. Jason McAnany
    Department of Ophthalmology and Visual Sciences, University of Illinois Chicago College of Medicine, Chicago, Illinois, United States
  • Jason C Park
    Department of Ophthalmology and Visual Sciences, University of Illinois Chicago College of Medicine, Chicago, Illinois, United States
  • Mirella Telles Salgueiro Barboni
    Department of Ophthalmology, Semmelweis Egyetem, Budapest, Budapest, Hungary
  • Jan J Kremers
    Department of Ophthalmology, Universitatsklinikum Erlangen, Erlangen, Bayern, Germany
  • Footnotes
    Commercial Relationships   Ditta Zobor None; Barbara Besztercei None; Balazs Lesch None; J. Jason McAnany None; Jason Park None; Mirella Barboni None; Jan Kremers None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 5417. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ditta Zobor, Barbara Besztercei, Balazs Lesch, J. Jason McAnany, Jason C Park, Mirella Telles Salgueiro Barboni, Jan J Kremers; Retinoschisin-1 (RS1) is required for proper functioning of luminance and red–green cone-opponent mechanisms. Invest. Ophthalmol. Vis. Sci. 2023;64(8):5417.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinoschisin-1 (RS1) protein is expressed in photoreceptors and bipolar cells and has a role in retinal cell adhesion. Mutations in the RS1 gene lead to X-linked retinoschisis (XLRS) in males and is in the focus of novel genetic therapies. The aim of this study is to investigate the pathophysiology of the retina in XLRS with electroretinogram (ERG) in response to heterochromatic stimulation at two different temporal frequencies aiming to emphasize cone-opponent and luminance responses.

Methods : Male patients and female carriers with genetically confirmed mutations in RS1 gene were included. ERGs were recorded, either preferentially activating the (red–green) opponent or the luminance pathway, and data from of XLRS patients (n=5) and carriers (n=5) were compared to normal male controls (n=10). The stimuli were heterochromatic sinusoidal modulations (HFM) at a mean luminance of 200 cd/m2. Three steps were measured with different red to green ratios for both 12 and 36 Hz. Furthermore, light-adapted ON and OFF responses were recorded using the sawtooth modulation.

Results : XLRS female carriers (mean age 46±6.8 years, range 39 to 54 years), and age-matched controls showed comparable HFM ERGs at both 12 and 36 Hz. XLRS male patients (mean age 24±3.3 years, range 20-28 years), on the other hand, showed lower responses at 36 Hz (F(2,35) = 9.928 and p < 0.001). Interestingly, the 12 Hz HFM pattern for the XLRS patients was consistent with a "luminance profile," rather than the “opponent profile” observed in the control and carrier groups. The "luminance profile" is normally observed at 36 Hz and is associated with the magnocellular pathway, whereas the “opponent profile” is normally observed at 12 Hz and is associated with the parvocellular pathway. We observed a greater deficit in the ON response than in the OFF response of the cone system in XLRS patients, as expected, but no significant differences between carriers and normal controls.

Conclusions : The absence of retinoschisin-1 is likely to disturb cone-opponent processing in XLRS patients. We hypothesize that asymmetric ON/OFF signals may hinder cone-opponent cells to be activated at 12 Hz. HFM protocols could be an objective and useful measure for natural history and therapeutic studies in XLRS.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×